Strategy and validation of a structure-based method for the discovery of selective inhibitors of PAK isoforms and the

Pei-Lu Song1, Gang Wang2, Yuan Su1

  • 1Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China.

Bioorganic Chemistry
|August 11, 2019
PubMed

Insights

Researchers discovered SPU-106, a novel small molecule inhibitor targeting p21 activated kinase 4 (PAK4). This compound effectively inhibits cancer cell invasion by blocking key signaling pathways without causing cytotoxicity, offering potential as an antitumor agent.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • p21 activated kinase 4 (PAK4) is a serine/threonine protein kinase implicated in cancer development.
  • Targeting PAK4 is a promising strategy for cancer therapy.

Purpose of the Study:

  • To discover novel and selective small molecule inhibitors of PAK4 using structure-based virtual screening.
  • To characterize the binding mode and inhibitory potential of the identified compound.

Main Methods:

  • Structure-based virtual screening and molecular docking.
  • Molecular dynamics (MD) simulations.
  • Kinase activity assays and western blot analysis to assess pathway inhibition.

Main Results:

  • A novel compound, SPU-106, was identified as an effective and selective PAK4 inhibitor.
  • SPU-106 binds to the PAK4 kinase domain with an IC50 of 21.36 μM.
  • SPU-106 inhibited SGC7901 cell invasion without cytotoxicity and suppressed PAK4/LIMK1/cofilin and PAK4/SCG10 signaling.

Conclusions:

  • Computational strategies successfully identified a selective PAK4 inhibitor.
  • SPU-106 demonstrates potential as an antitumor agent for further preclinical development.

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
14.8K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.9K
Reliability and Validity01:29

Reliability and Validity

Reliability and validity are two important considerations that must be made with any type of data collection. Reliability refers to the ability to consistently produce a given result. In the context of psychological research, this would mean that any instruments or tools used to collect data do so in consistent, reproducible ways.
13.7K
Titrimetric Methods: Types and Commonly Used Strategies01:08

Titrimetric Methods: Types and Commonly Used Strategies

In chemistry, titrimetric methods are broadly classified into three types: volumetric, gravimetric, and coulometric. Volumetric titrations involve measuring the volume of a titrant of known concentration that is required to react completely with an analyte. In gravimetric titrations, the standard solution reacts with the analyte to form an insoluble precipitate, which is filtered, dried, and weighed. In coulometric titrations, current is applied to an electrochemical reaction until the reaction...
2.4K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.1K